First Reported Case Series of Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD)

被引:1
|
作者
Gagliardi, Thomas A. [1 ]
Milner, Jordan [2 ]
Paula, Cassey [1 ]
Ozkayank, Mehmet [2 ]
Levendoglu-Tugal, Oya [2 ]
Hochberg, Jessica C. [2 ]
Rosenblum, Jeremy [2 ]
Gardenswartz, Aliza [2 ]
Cairo, Mitchell S. [2 ]
Steinberg, Amir [3 ]
机构
[1] New York Med Coll, Valhalla, NY USA
[2] New York Med Coll, Dept Pediat, Valhalla, NY USA
[3] Westchester Med Ctr, New York Med Coll, Hawthorne, NY USA
关键词
D O I
10.1182/blood-2021-148071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4885
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD): The First Reported Use in Pediatric Patients
    Gagliardi, Thomas A.
    Milner, Jordan
    Cairo, Mitchell S.
    Steinberg, Amir
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (09)
  • [2] Ruxolitinib for steroid-refractory graft-versus-host disease: A case series
    Lancman, Guido
    Coltoff, Alexander
    Steinberg, Amir
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (03) : 611 - 613
  • [3] GRAFT-VERSUS-HOST DISEASE (GVHD)
    VOLCPLATZER, B
    HAUTARZT, 1992, 43 (10): : 669 - 677
  • [4] Costs and Adverse Events Associated with Ibrutinib or Ruxolitinib in Chronic Graft-Versus-Host Disease
    Bachier, Carlos
    Eiznhamer, David
    Milgroom, Andrew
    Lenco, Mara
    Patel, Nayan
    Skaar, Jeffrey Rolf
    BLOOD, 2020, 136
  • [5] Ruxolitinib for Therapy of Graft-versus-Host Disease
    Neumann, Thomas
    Schneidewind, Laila
    Weigel, Martin
    Plis, Andrzej
    Vaizian, Rem
    Schmidt, Christian A.
    Krueger, William
    BIOMED RESEARCH INTERNATIONAL, 2019, 2019
  • [6] Ruxolitinib for Chronic Graft-versus-Host Disease
    Shibusawa, Motoharu
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1631 - 1631
  • [7] Ruxolitinib for treatment of Graft-versus-Host Disease
    Krueger, W. H.
    Neumann, T.
    Weigel, M.
    Plis, A.
    Schneidewind, L.
    Vaizian, R.
    Schmidt, C. A.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 70 - 71
  • [8] Ruxolitinib for Acute Graft-versus-Host Disease
    Gratwohl, Alois
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (05): : 501 - 501
  • [9] Ruxolitinib for the treatment of graft-versus-host disease
    Ali, Haris
    Salhotra, Amandeep
    Modi, Badri
    Nakamura, Ryotaro
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (04) : 347 - 359
  • [10] Ruxolitinib for therapy of graft-versus-host disease
    Plis, A.
    Neumann, T.
    Schneidewind, L.
    Weigel, M.
    Vaizian, R.
    Schmidt, C.
    Krueger, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 205 - 205